Home › Funds › Franklin, Parlapiano, Turner & Welch, LLC › NVS

Franklin, Parlapiano, Turner & Welch, LLC position in NVS

Novartis Ag Sponsored ADR · Health Care

Franklin, Parlapiano, Turner & Welch, LLC reported holding 61,440 shares of NVS (Novartis Ag Sponsored ADR) in its Q3 2026 13F filing — a position valued at US$8.8M, representing 1.96% of its reported portfolio and ranking #13 among its reported holdings. Franklin, Parlapiano, Turner & Welch, LLC has disclosed NVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)61.44K sh
Reported value held$8.76M
Portfolio Weight1.96%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Franklin, Parlapiano, Turner & Welch, LLC's NVS position evolved

Franklin, Parlapiano, Turner & Welch, LLC first disclosed a stake in NVS in Q3 2023 at 76,914 shares (US$7.8M). The position peaked in Q4 2025 at 70,511 shares, worth US$10.2M. Across 13 filings, Franklin, Parlapiano, Turner & Welch, LLC increased the stake 0 time(s), trimmed it 6 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 61,440 shares valued at US$8.8M — a reduction of -1,974 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 76.91K $7.83M New
Q4 2023 76.08K $7.68M Reduce
Q1 2024 75.79K $7.33M Hold
Q2 2024 75.48K $8.04M Hold
Q3 2024 75.24K $8.65M Hold
Q4 2024 75.45K $7.34M Hold
Q1 2025 75.62K $8.43M Hold
Q2 2025 75.84K $9.18M Hold
Q3 2025 73.98K $9.49M Reduce
Q4 2025 70.51K $10.18M Reduce
Q1 2026 65.09K $9.60M Reduce
Q2 2026 63.41K $9.94M Reduce
Q3 2026 61.44K $8.76M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NVS and 13F data

NVS (Novartis Ag Sponsored ADR) is a Health Care company. 20 other funds we track also report a position in NVS — the largest reported positions include Fisher Asset Management, LLC (US$2.39B), PRIMECAP MANAGEMENT CO/CA/ (US$938.9M), LOOMIS SAYLES & CO L P (US$689.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NVS

All NVS fund holders →

FAQ

How long has Franklin, Parlapiano, Turner & Welch, LLC held NVS?

Franklin, Parlapiano, Turner & Welch, LLC has disclosed NVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Franklin, Parlapiano, Turner & Welch, LLC's current position in NVS?

As of Q3 2026, Franklin, Parlapiano, Turner & Welch, LLC holds 61.44K shares of NVS (Novartis Ag Sponsored ADR), valued at $8.76M, representing 1.96% of its reported portfolio and ranking #13.

Has Franklin, Parlapiano, Turner & Welch, LLC been buying or selling NVS?

In the latest 13F filing (Q3 2026), Franklin, Parlapiano, Turner & Welch, LLC reduced its position in NVS. The position peaked in Q4 2025 at 70.51K shares.

Which other funds hold NVS?

Other major institutional holders of NVS include Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, LOOMIS SAYLES & CO L P, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.